Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 270 participants.
Also called NCT05750576
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 270 participants
- Registry
-
NCT05750576
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT05750576. Randomized; no masking; primary purpose other. Start 2023-06-15 (actual); primary completion 2025-06-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
- Acronym
- DRESSING-ECMO
- Condition
- Cardiogenic Shock
- Condition
- Extracorporeal Membrane Oxygenation Complication
- Condition
- Acute Respiratory Distress Syndrome
- Condition
- Infections
- Intervention (Device)
- Chlorhexidine-impregnated dressings
- Intervention (Device)
- Non impregnated dressings
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct05750576- Content hash
01637a94b14543366575662de3d616bff0fd45738ca0146a50f5842b46c438ec